Sok Cheng Soh, MBA Chief Financial Officer
Sok has more than25 years of experience in finance and public accounting, including treasury, controllership, operations, and financial planning. Sok was previously Chief Financial Officer of Torque Therapeutics, which combined with Cogen Immune Medicine to form Repertoire. Prior to joining Torque, she was Vice President of Treasury and Tax at Bioverativ, a biotechnology company acquired in 2018 by Sanofi, where she established and built the company’s tax and treasury capabilities. Previously, she was Assistant Treasurer at Boston Scientific, where she led capital market initiatives, financial risk management, and treasury operations. Before joining Boston Scientific in 2011, she held positions of increasing responsibility at United Technologies where her experience included a variety of global finance roles. Sok received an MBA from the University of Chicago Booth School of Business and a BA in accounting from the University of Singapore.